1400 16th Street
San Francisco, CA 94103
United States
415 374 7782
https://www.invitae.com
Settore/i:
Settore:
Impiegati a tempo pieno: 1.700
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Dr. Randal W. Scott Ph.D. | Co-Founder & Chairman of the Board | 50k | N/D | 1958 |
Mr. Kenneth D. Knight | President, CEO & Director | 1,4M | N/D | 1961 |
Mr. Thomas R. Brida | General Counsel, Chief Compliance Officer & Secretary | 776,72k | N/D | 1971 |
Ms. Ana J. Schrank | Chief Accounting Officer & CFO | N/D | N/D | 1966 |
Dr. David B. Sholehvar M.D. | Chief Operating Officer | N/D | N/D | 1968 |
Ms. Hoki Luk | Head of Investor Relations and Capital Markets & Corporate Development | N/D | N/D | 1976 |
Ms. Shelly D. Guyer | Chief Sustainability Officer | 430,44k | N/D | 1960 |
Ms. Desarie French | Chief Talent Officer | N/D | N/D | N/D |
Dr. W. Michael Korn M.D. | Chief Medical Officer | N/D | N/D | N/D |
Mr. Robert Guigley | Chief Commercial Officer | N/D | N/D | N/D |
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. On February 13, 2024, Invitae Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.
L'ISS Governance QualityScore di Invitae Corporation al 29 aprile 2024 è 9. I criteri di valutazione fondamentali sono revisione: 4; Consiglio di Amministrazione: 10; diritti degli azionisti: 7; retribuzione: 9.